. Dr. Khedr is highly rated in 8 conditions, according to our data. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, and Retinal Artery Occlusion.

. Dr. Kilty is highly rated in 3 conditions, according to our data. Her top areas of expertise are Strabismus, Glaucoma, Blepharitis, and Esotropia.

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is highly rated in 25 conditions, according to our data. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Philip Ferrone is an Ophthalmologist in Elmhurst, New York. Dr. Ferrone is highly rated in 23 conditions, according to our data. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Coats Disease, and Vitrectomy.

Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, Macular Degeneration, Macular Holes, Macular Pucker, Diabetic Retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the diagnosis and treatment of Retinal Diseases. He has given lectures around the world.He has a remarkable number of “firsts” in retinal diseases including the development of autofluorescence imaging using a fundus camera and the first practical method to image deeper structures in the eye with optical coherence tomography. These imaging methods now are used around the world. He has described many new findings and diseases of the eye and helped develop many novel treatments. He has developed numerous surgical instruments that were named after him and holds patents for ophthalmic inventions.He is the recipient of the Richard and Hilda Rosenthal Foundation Award in the Visual Sciences, the Senior Honor Award from the American Society of Retinal Surgeons, and the Senior Achievement Award from the American Academy of Opthalmology and the Prix Soubrane de la Recherche en Ophthalmologie, Award of Merit from the Retina Society, the Henkind Award, Coscas Award, Nataraja Pillai Award, W. Richard Green MD Award, George Theodossiadis Award, Founders Award, American Society of Retinal Surgeons, Life Achievement Honor Award, and the American Academy of Ophthalmology. Dr. Spaide is highly rated in 16 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Geographic Atrophy, and Vitrectomy.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is highly rated in 15 conditions, according to our data. His top areas of expertise are Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

Kim Landzberg is an Ophthalmologist in Riverdale, New York. Dr. Landzberg is highly rated in 12 conditions, according to our data. Her top areas of expertise are Glaucoma, Cataract, Allergic Conjunctivitis, and Conjunctivitis (Pink Eye).

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is highly rated in 10 conditions, according to our data. His top areas of expertise are Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is highly rated in 8 conditions, according to our data. His top areas of expertise are Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy.

Dr. Jeffrey M. Liebmann is a Professor of Ophthalmology, Glaucoma Service Director, and Vice-Chair for the Department of Ophthalmology at Columbia University Medical Center.Dr. Jeffrey M. Liebmann graduated from Boston University School of Medicine, completed his ophthalmology residency at the State University of New York/Downstate Medical Center, and his glaucoma fellowship at the New York Eye and Ear Infirmary. Dr. Liebmann serves as Shirlee and Bernard Brown Professor, Vice-Chair, and Director of the Glaucoma Division of the Department Ophthalmology at Columbia University Medical Center. He is a fellow of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology and American College of Surgeons. Dr. Liebmann is currently Editor-in-Chief of Journal of Glaucoma, a member of the Board of Governors of the World Glaucoma Association and Board of Directors of The Glaucoma Foundation and Secretary-Treasurer of the New York Glaucoma Society. Dr. Liebmann is a past-President of the World Glaucoma Association, American Glaucoma Society, and the New York Society for Clinical Ophthalmology and was co-founder of the New York Glaucoma Research Institute, the American Glaucoma Society Foundation and ASCRS Glaucoma Day.In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Liebmann is Principal Investigator for the NIH African Descent and Glaucoma Evaluation Study (ADAGES) and Ocular Hypertension Treatment Study (OHTS III) at Columbia University and is the author and/or co-author of more than 1000 medical and scientific papers, book chapters, and abstracts. He has lectured widely in the United States and abroad on glaucoma diagnosis and management. His current main areas of research interest include the causes of glaucoma, glaucoma progression, glaucoma surgery, ocular imaging, and neuroprotection. Dr. Liebmann is highly rated in 7 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy.

Aakriti Shukla MD, MSc is an Associate Professor of Ophthalmology at CUMC and Attending Ophthalmologist at the New York Presbyterian Hospital. Dr. Shukla is a board-certified ophthalmologist and specializes in the medical and surgical management of glaucoma and cataracts. Her surgical expertise includes minimally invasive glaucoma surgery, traditional glaucoma surgery, glaucoma laser surgery, and cataract surgery.Dr. Shukla completed her undergraduate studies as a Trustee and Renaissance Scholar at the University of Southern California. She received her medical degree at Columbia University College of Physicians and Surgeons in New York City, where she was awarded a Doris Duke Clinical Research Fellowship and earned the Edith and Denton McKane Memorial Award for Outstanding Research in Ophthalmology. She completed her training as an ophthalmology resident and served as chief resident at Columbia University's Harkness Eye Institute. She earned a Master of Science degree at Columbia University’s Mailman School of Public Health in Patient-Oriented Research. She pursued further glaucoma subspecialty training at the Wilmer Eye Institute at Johns Hopkins University in Baltimore, MD. Prior to her appointment at Columbia University, she served as glaucoma faculty at the Wills Eye Hospital in Philadelphia, PA.Dr. Shukla has published numerous peer-reviewed articles, book chapters, and has been invited to speak nationally and internationally on her patient care and research. She serves on the editorial boards of Ophthalmology and Ophthalmology Glaucoma. She is continually inspired by her patients and aims to improve their quality of life while treating their glaucoma. Dr. Shukla is highly rated in 7 conditions, according to our data. Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal.

Anne Barmettler, MD, is Director, Plastic and Reconstructive Surgery Division and Professor, Ophthalmology and Visual Sciences and Surgery at Montefiore Einstein. Dr. Barmettler’s clinical specialty is oculoplastic surgery, which involves plastic and reconstructive surgery of the upper face, eyelids, orbit (bony cavity around the eye), and lacrimal (tear) system. Dr. Barmettler is highly rated in 6 conditions, according to our data. Her top areas of expertise are Eyelid Drooping, Ptosis, Ectropion, and Thyroid Eye Disease.

John Kim is an Ophthalmologist in New York, New York. Dr. Kim is highly rated in 6 conditions, according to our data. His top areas of expertise are Dry Eye Syndrome, Glaucoma, Ocular Hypertension (OHT), and Cataract.

Saadia Rashid is an Ophthalmologist in Bronx, New York. Dr. Rashid is highly rated in 6 conditions, according to our data. Her top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration.

Dr. George A. (Jack) Cioffi is an internationally recognized glaucoma scientist and clinician and is the Edward S. Harkness Professor and Chair of the Department of Ophthalmology at Columbia University Vagelos College of Physicians and Surgeons since 2012. He also holds the Jean and Richard Deems Endowed Professorship and is the Ophthalmologist-in-Chief at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center. From 2014 to 2023, Dr. Cioffi served as the President of ColumbiaDoctors, the multi-specialty faculty practice organization of more than 2,500 clinicians from Columbia University Irving Medical Center and was concurrently appointed Vice Dean of Clinical Affairs. Dr. Cioffi formerly held the Richard G. Chenoweth Chair of Ophthalmology at the Devers Eye Institute and was the Chief Medical Officer & Senior Vice President at Legacy Health System in Portland, Oregon. He received his medical degree at the University of South Carolina, completed a residency in ophthalmology at the University of Maryland where he also served as Chief Resident, and a fellowship in Research & Clinical Glaucoma at Devers Eye Institute under Dr. E. Michael Van Buskirk. Subsequently, he completed the inaugural Harvard Business School program in Managing Healthcare Delivery.Dr. Cioffi is the Editor-in-Chief of Journal of Academic Ophthalmology, the official journal of the Association of University Professors of Ophthalmology (AUPO). As well, he is Editor Emeritus of the Journal of Glaucoma, after serving for 10 years as the Editor-in-Chief, and he is the past Chair of the Basic and Clinical Science Course for the American Academy of Ophthalmology. He is the Chair of the Scientific Advisory Committee for the Glaucoma Research Foundation in San Francisco. He is a past President of the Oregon Academy of Ophthalmology and has served as a member of the FDA Ophthalmology/Dermatology Advisory Committee for drug approval. He also served on the Board of Directors for the Foundation for Medical Excellence and was selected by the Governor John Kitzhaber to serve on the Oregon Health Policy Board’s Outcomes & Quality taskforce. Dr. Cioffi, a physician for more than 30 years, has published over 250 articles, has enjoyed support from the National Eye Institute of the National Institutes of Health for more than two decades. He has delivered numerous named lectures and has received the Honor Award, the Senior Honor Award and two Secretariat Awards from the AAO. He has mentored more than 50 clinical and post-doctoral fellows over his career. These clinicians and scientists are now at academic institutions and in practices around the U.S., Canada, Europe, Asia, and Australia. Dr. Cioffi is highly rated in 5 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal.

Celso Tello is an Ophthalmologist in New York, New York. Dr. Tello is highly rated in 5 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Vitrectomy.

Umar Mian is an Ophthalmologist in Bronx, New York. Dr. Mian is highly rated in 5 conditions, according to our data. His top areas of expertise are Diabetic Retinopathy, Retinopathy of Prematurity, Kallikrein Hypertension, Retinal Artery Occlusion, and Vitrectomy.

Dr. C. Gustavo De Moraes is an Associate Professor of Clinical Ophthalmology at the Columbia University Medical Center and Attending Physician at New York Presbyterian Hospital. He sees patients with or at risk of developing glaucoma. Dr. De Moraes completed a glaucoma fellowship at the New York Eye and Ear Infirmary (NYEEI), later directing the Glaucoma Research Unit at the Einhorn Clinical Research Center of the NYEEI. He was also a Research Associate Professor of Ophthalmology at New York University (NYU).Dr. De Moraes is a member of the American Medical Association (AMA), American College of Surgeons (ACS), American Academy of Ophthalmology (AAO), Association for Research in Vision and Ophthalmology (ARVO), American Glaucoma Society (AGS), New York Glaucoma Society (NYGS), Ophthalmic Laser and Imaging Society (OLIS). He is past chair of the Associate Advisory Board of the World Glaucoma Association (WGA), and Education Committee of the International Council of Ophthalmology (ICO). Dr. De Moraes is the current Associate Editor for the journal Investigative Ophthalmology and Vision Sciences (IOVS), and co-chair of Glaucoma Progression Scholas (GPS). Dr. De Moraes has twice received the American Academy of Ophthalmology (AAO) Achievement Award. His clinical research has been funded by the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Research to Prevent Blindness (RPB). Dr. De Moraes is highly rated in 4 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Vitrectomy.

Anurag Shrivastava, MD serves as Assistant Dean, Montefiore Medical Center and Associate Designated Institutional Officer, Graduate Medical Education. He is an attending physician, Glaucoma and Associate Professor, Ophthalmology and Visual Sciences at Montefiore Einstein. Dr. Shrivastava is fellowship trained in glaucoma, and provides comprehensive eye care for patients primarily with anterior segment disease. Dr. Shrivastava is highly rated in 3 conditions, according to our data. His top areas of expertise are Glaucoma, Cataract, Ocular Hypertension (OHT), Cataract Removal, and Trabeculectomy.

Samer Farah is an Ophthalmologist in Bronx, New York. Dr. Farah is highly rated in 3 conditions, according to our data. His top areas of expertise are Diabetic Retinopathy, Retinal Vein Occlusion, Retinal Artery Occlusion, and Late-Onset Retinal Degeneration.

Mark Kupersmith is an Ophthalmologist in New York, New York. Dr. Kupersmith is highly rated in 52 conditions, according to our data. His top areas of expertise are Papilledema, Increased Intracranial Pressure, Pseudotumor Cerebri Syndrome, Optic Neuritis, and Thymectomy.

Dr. Schultz earned his medical degree at Mount Sinai School of Medicine and served as the Harold G Scheie fellow in glaucoma at the University of Pennsylvania. He is an associate examiner for the American Board of Ophthalmology and received an honorary award from the American Academy of Ophthalmology. He is presently Chairman of the Scientific Advisory Board of the Friends of the Congressional Glaucoma Caucus. He is currently investigating the effect of Flomax on the iris dilator muscle to help improve surgical outcomes in patients undergoing cataract surgery. In addition, he is involved in advancing the surgical uses for the Trabectome®, a new surgical procedure for the treatment of glaucoma developed in part by a physician at Montefiore. Dr. Schultz is highly rated in 2 conditions, according to our data. His top areas of expertise are Glaucoma, Cataract, Dry Eye Syndrome, Ocular Hypertension (OHT), and Cataract Removal.

Nathan Radcliffe is an Ophthalmologist in Bronx, New York. Dr. Radcliffe is highly rated in 36 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Cataract Removal.

Patrick Oellers is an Ophthalmologist in Liverpool, New York. Dr. Oellers is highly rated in 35 conditions, according to our data. His top areas of expertise are Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

Mark Breazzano is an Ophthalmologist in Liverpool, New York. Dr. Breazzano is highly rated in 34 conditions, according to our data. His top areas of expertise are Endophthalmitis, Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Vitrectomy.